Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Mergers & Acquisitions
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.
February 1, 2023
Matrix Medical Network sells laboratory service line to Karrington Clinical Laboratory
The transition of ownership is part of an overall strategy Matrix announced last year to refocus its portfolio of services on in-home health and care assessments.
January 4, 2023
Thermo Fisher Scientific, Heska complete previously announced acquisitions
Thermo Fisher completed its previously-announced acquisition of specialty diagnostics firm The Binding Site Group, while Heska closed the acquisition of point-of-care test developer LightDeck Diagnostics.
January 3, 2023
Fujifilm to enter digital pathology space with acquisition of Inspirata digital pathology platform
The acquisition signals Fujifilm's entry into the digital pathology market. At present, 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog pathology.
December 19, 2022
Integrated DNA Technologies acquires Invitae’s Archer NGS research assays for $48M
IDT said that the addition of next-generation sequencing research panels and bioinformatics expands IDT's position as an oncology research solutions provider.
December 20, 2022
Quest Diagnostics, Northern Light Health broadening access to laboratory services in Maine
Under a strategic agreement, Quest will acquire select assets of Northern Light Health's outreach laboratory services business in an all-cash transaction.
December 8, 2022
Most Popular
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
Roche reports flat diagnostics revenue growth for 2022
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
CompuGroup Medical acquires Medicus Laboratory Information Systems
The Medicus laboratory information system (LIS) has been installed in more than 1,000 laboratories nationwide.
December 8, 2022
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
Quest said that as a result of the acquisition, physicians and patients in northeastern Ohio will gain access to its test menu and broad health plan relationships.
November 28, 2022
Fulgent Genetics acquires Fulgent Pharma for $100M
Fulgent said that through the acquisition, it will evolve from a genomic diagnostics business to a fully integrated precision medicine company with a focus on oncology.
November 8, 2022
Thermo Fisher Scientific to acquire specialty diagnostics firm The Binding Site Group for $2.6B
U.K.-based Binding Site Group provides specialty diagnostic assays and instruments for the diagnosis and management of blood cancers and immune system disorders.
October 31, 2022
PCL acquires molecular diagnostics testing firm Infinity Laboratories
The acquisition will provide PCL a location in the southern United States from which to bring its testing services to the area.
October 18, 2022
Liquid biopsy diagnostics firm DiaCarta going public on NYSE through SPAC
The equity valuation of DiaCarta under the proposed combination is $460 million. DiaCarta is a translational genomics and molecular diagnostics firm.
October 14, 2022
Page 1 of 7
Next Page
